undefined

Posts

undefined

Followers

User since undefined NaN
Personal Finance

After its blockbuster IPO, Anthropic's next challenge is finding a hit bigger than Claude Code

By Stephen Council,

1 hours ago

https://img.particlenews.com/image.php?url=2hxiCR_1HH8c7rB00

https://img.particlenews.com/image.php?url=4XBLBE_1HH8c7rB00
Anthropic CEO Dario Amodei.
  • Can Anthropic make lightning strike twice?
  • The company's hit with Claude Code was big enough to fuel a blockbuster initial public offering.
  • Now, Anthropic CEO Dario Amodei sets his sights on the next cash cows — and admits uncertainty.

Anthropic's new era has arrived and will require an answer to one major question: What's next after AI coding?

The company behind Claude went public on Thursday in a blockbuster IPO and closed the trading day with a $1.7 trillion valuation. It's a milestone for Anthropic and the AI industry, and the firm is now flush with cash: it raised $81 billion in the listing and another $26 billion in a concurrent share sale.

Anthropic CEO Dario Amodei will spend it on AI. Few inventions have ever cost so much, or seen this scale of competition. Anthropic now has a valuation comparable to that of some of the world's largest businesses and generates only a fraction of their revenue. To thrive on the public markets, it will need to disprove skeptics, fend off rivals, surprise scientists, and transform industries.

That will all mean finding a follow-up to the smash success of Claude Code, a coding tool that can autonomously read, edit, and run software.

Anthropic's fortunes changed entirely with Claude Code. At less than two years old, the product has already driven billions in revenue to Anthropic, upturned the lives of software engineers, and forced other AI developers into catch-up mode.

While Anthropic will keep raking in cash from the ultra-popular product, it needs to rake in much, much more to justify its valuation. The company's IPO prospectus lays out that ambition in the grandest possible terms: it wants to make AI that can "revolutionize every area of human endeavor," which "may well represent the greatest economic opportunity in history."

For its next cash cow, Anthropic has its eyes set on other industries. In its IPO prospectus, it called cybersecurity "one of our most important near-term opportunities," thanks to both Claude's hacking skills and the growing need for defense in the AI age.

Life sciences is another major target. The prospectus said that global pharmaceutical spend is expected to exceed $2 trillion this year, and that most of the largest companies are already spending heavily with Anthropic.

Last Friday, Amodei talked up his company's early progress in biology and robotics during a pitch to investors. He said the growth of his technology's capabilities will ripple outward beyond code.

He also expressed doubt: "For any given field, the skeptics could be right."

Dario Amodei says AI coding is 'starting to mature'

The economics of the AI industry are new and unproven. In 2019, OpenAI's Sam Altman told investors that his plan was to ask a smart AI model how to generate financial returns. In its early days, Anthropic had no plans to release a product.

If ChatGPT's 2022 release became the breakthrough moment for AI, Claude Code's rise in popularity last year became a breakthrough for the industry's finances.

Claude Code rakes in plenty of cash for Anthropic because it works. Software engineers — generally a speedy group to adopt new technologies — have watched the tool run their tests, fix their bugs, and build entire features for their bosses. The code repository GitHub saw developers push far more code changes over a recent twelve-month stretch than in 2024 and 2025 combined.

Coding is also complex. A Claude Code coding session burns through computing power as the AI takes step after step. Anthropic charges for this consumption, so the harder and more complicated the work, the more money the company will make.

Top Claude Code users on business plans spend 20 times as much money as users who don't use the tool, Anthropic wrote in its IPO prospectus.

Still, the company's revenue growth decelerated in its last reported quarter — there's fierce competition, a struggle to diffuse the tech, and limited computing power.

Amodei said at the JPMorgan event that there's a long way to go in AI coding and that the company needs to drive broader adoption among large companies. The category is "starting to mature," he said.

"I think the excitement is going to move to these new areas which are going to be much larger than coding, in the same way that coding was much larger than chatbots," Amodei said.

Dario Amodei and Anthropic look beyond coding

As Anthropic looks beyond coding, Amodei's predictions in biology have been nothing short of utopian. He said at the Friday JPMorgan event that he sees "incredible potential for us to solve biology in an absolutely incredible way," and that "within a few years," each of the slowdowns in life sciences will be addressed by AI.

In another IPO promotion from the company's road show, he said, "cancer, Alzheimer's, heart disease, mental illness — these will be relics of the past in, I think, less than a decade."

Pharmaceutical leaders and doctors have thrown water on the hype. Dave Ricks, the CEO of Eli Lilly, wrote this month that while he was excited about AI, he thinks progress will still be incremental and that Amodei's within-a-decade prediction isn't likely to come true.

Amodei said at the JPMorgan event that AI has a "tendency" to go little by little, then suddenly break through in areas that have resisted other tech.

"They've seen so many technologies in the past try to solve their problems, and they've seen that their problems are fiendishly difficult. Same with mathematics, same with coding," Amodei said.

He and the company have also floated robotics, manufacturing, physics, and materials science as target areas. Anthropic has already been pouring investment into more specific research. It's ultimately unclear if the bets will turn out as well as coding did.

Anthropic begins a new high-wire act

Investors are clearly believing Anthropic's message. The company raised its opening price after experiencing excess demand during its IPO road show, and its valuation touched $2 trillion during its first trading day.

Paul Kedrosky, an investor at SK Ventures, said he doesn't expect Anthropic to find another coding-sized hit. He thinks the company's revenue growth will slow and look "nothing like" the explosion it saw over the last year.

Anthropic is bringing on the cold light of the public markets as it plans to spend like mad. It's committed around $900 billion toward infrastructure for computing power, with about half due by 2030. That will require substantial revenue to fund.

Amodei called the spend on compute his company's "deepest business dilemma" at the JPMorgan event, adding that he doesn't know how the technology "is going to transfer to the creation of economic value on the business side."

That's a tricky uncertainty for the company, and for investors to reckon with. Although he said he's playing it conservatively, the stakes are huge. On Dwarkesh Patel's podcast in February, the CEO said overestimating revenue at, for example, $1 trillion in a year, would be catastrophic.

"If my revenue is not $1 trillion dollars, if it's even $800 billion, there's no force on earth, there's no hedge on earth that could stop me from going bankrupt if I buy that much compute," Amodei said.

Have a tip? Contact this reporter via email at scouncil@businessinsider.com, or over text, Signal, Telegram, or WhatsApp at 415-757-8198. Use a personal email address, a non-work WiFi network, and a non-work device; here's our guide to sharing information securely.

Read the original article on Business Insider

Comments